Hackers carried out a cyberattack on the European Medicines Agency (EMA) and gained access to the documents on the admission to the use of the coronavirus vaccine developed by the American company Pfizer and the German company BioNTech.
This was announced on Wednesday by representatives of the companies, reports Reuters.
At the same time, Pfizer and BioNTech said that, according to their information, the attack did not touch the personal data of the test participants, and the EMA “assured us that the cyberattack will not affect the timing of the vaccine verification.”
The EMA is currently evaluating the safety and efficacy of the vaccine for EU approval.
Both companies said they were briefed by the EMA about the cyberattack, which “reviewed some documents related to the Pfizer and BioNTech COVID-19 vaccine application.”